EY data show that India had more IPOs in the first three quarters of the year than anywhere else in the world.

Navan is perhaps the most high-profile IPO over the past month, as the SEC's filing process has stalled with 90% of staff furloughed.

With the shutdown ongoing, Evommune plans to close its IPO on Nov. 5 via a Securities Act clause that allows registrations to come into effect after a certain window has passed.

Navan's shares started trading 12% below their initial public offering price on Thursday, as the travel technology company faced choppy market conditions amid a prolonged U.S. government shutdown.

OpenAI has been laying the groundwork for an initial public offering (IPO) of up to $1 trillion, according to a Reuters report. This could be one of the biggest IPOs of all time.

Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 to $17 per share. | Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price between $15 and $17 per share.

Shares in British lender Shawbrook jumped as much as 8% in early Thursday trade following London's biggest initial public offering by a UK-based company in two years.

Medline Inc. eyes a $5B IPO to reduce debt amid strong growth in the medical disposables market. Click here to read my latest analysis of MDLN stock.

The IPO preparations follow a restructuring of OpenAI completed on October 28 that reduced the company’s reliance on Microsoft, which has committed to investments of $13 billion and now owns about 27 percent of the company. OpenAI was most recently valued around $500 billion in private markets.

The Government Shutdown Has Killed IPOs. Navan Offers a ‘Glimmer of Joy.’

Orkla India IPO entered its second day of bidding today. While the GMP has seen a moderation, analysts have also retained neutral on the IPO.